ABVC Biopharma Inc Working Capital to Net Assets Ratio
ABVC Biopharma Inc working capital to net assets ratio. ABVC Biopharma Inc (ABVC) has a Working Capital to Net Assets ratio of -43.1% as of June 2026. Working capital of $-5.28 Million (current assets of $411.73K minus current liabilities of $5.69 Million) is measured against net assets of $12.27 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check ABVC Biopharma Inc (ABVC) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of ABVC Biopharma Inc (2002–2025)
Working capital to net assets ratio of ABVC Biopharma Inc from 2002 to 2025. This chart shows how ABVC Biopharma Inc's Working Capital to Net Assets ratio has evolved across 22 annual periods from 2002 to 2025. As of June 2026, the ratio stands at -43.1%, reflecting working capital of $-5.28 Million against net assets of $12.27 Million USD. See ABVC Biopharma Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
ABVC Biopharma Inc Working Capital to Net Assets Ratio by Year (2002–2025)
ABVC Biopharma Inc working capital to net assets ratio by year from 2002 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for ABVC Biopharma Inc from 2002 to 2025, covering 22 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of ABVC Biopharma Inc.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -27.5% | $-3.66 Million | $13.30 Million | $2.50 Million | $6.16 Million | ▲ +577.1 pp |
| 2024 | -604.7% | $-4.38 Million | $723.96K | $2.18 Million | $6.56 Million | ▼ -250.1 pp |
| 2023 | -354.6% | $-4.45 Million | $1.25 Million | $1.66 Million | $6.10 Million | ▼ -298.9 pp |
| 2022 | -55.7% | $-2.56 Million | $4.59 Million | $2.99 Million | $5.54 Million | ▼ -100.3 pp |
| 2021 | 44.7% | $3.96 Million | $8.87 Million | $7.65 Million | $3.69 Million | ▲ +21.8 pp |
| 2020 | 22.8% | $1.33 Million | $5.82 Million | $6.17 Million | $4.84 Million | ▼ -4732.9 pp |
| 2019 | 4755.7% | $-5.94 Million | $-124.82K | $878.24K | $6.81 Million | ▲ +4660.6 pp |
| 2018 | 95.2% | $-5.47 Million | $-5.75 Million | $96.27K | $5.57 Million | ▲ +230.4 pp |
| 2017 | -135.3% | $-3.33 Million | $2.46 Million | $760.97K | $4.09 Million | ▼ -235.3 pp |
| 2016 | 100.0% | $-6.52 Million | $-6.52 Million | $18.64K | $6.54 Million | ▲ +222.1 pp |
| 2015 | -122.1% | $-35.52K | $29.08K | $3.63K | $39.15K | ▼ -16.9 pp |
| 2014 | -105.3% | $-32.17K | $30.56K | $1.86K | $34.03K | ▼ -223.5 pp |
| 2011 | 118.3% | $-1.73 Million | $-1.46 Million | $101.92K | $1.83 Million | ▲ +9.6 pp |
| 2010 | 108.7% | $-3.25 Million | $-2.99 Million | $33.15K | $3.29 Million | ▼ -17.0 pp |
| 2009 | 125.7% | $-2.53 Million | $-2.01 Million | $1.40K | $2.53 Million | ▼ -14.8 pp |
| 2008 | 140.5% | $-1.74 Million | $-1.24 Million | $999.48K | $2.74 Million | ▲ +152.1 pp |
| 2007 | -11.6% | $-33.67K | $290.29K | $880.17K | $913.84K | ▼ -111.6 pp |
| 2006 | 100.0% | $35.27K | $35.27K | $88.34K | $53.07K | ▲ +0.0 pp |
| 2005 | 100.0% | $60.67K | $60.67K | $63.40K | $2.72K | ▲ +0.0 pp |
| 2004 | 100.0% | $87.34K | $87.34K | $90.31K | $2.96K | ▲ +0.0 pp |
| 2003 | 100.0% | $80.00K | $80.00K | $110.00K | $30.00K | ▲ +0.0 pp |
| 2002 | 100.0% | $10.00K | $10.00K | $40.00K | $30.00K | — |